Literature DB >> 21131630

Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii.

D W Wareham1, N C Gordon.   

Abstract

Performance of CHROMagar Acinetobacter was assessed for the selective isolation and identification of Acinetobacter baumannii. The medium was effective in suppressing the growth of other Gram-positive and Gram-negative species while the addition of KPC supplement ensured growth of only carbapenem resistant A baumannii.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131630     DOI: 10.1136/jcp.2010.083469

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp.

Authors:  J Moran-Gilad; A Adler; D Schwartz; S Navon-Venezia; Y Carmeli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-28       Impact factor: 3.267

2.  Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii.

Authors:  Michael Hornsey; David W Wareham
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

Review 3.  Carbapenem Resistance: A Review.

Authors:  Francis S Codjoe; Eric S Donkor
Journal:  Med Sci (Basel)       Date:  2017-12-21

4.  Modified CHROMagar Acinetobacter medium for direct detection of multidrug-resistant Acinetobacter strains in nasal and rectal swab samples.

Authors:  Wonkeun Song; Jacob Lee; Taek-Kyung Kim; Min-Jeong Park; Han-Sung Kim; Jae-Seok Kim
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

5.  Rapid identification of nosocomial Acinetobacter baumannii isolated from a surgical intensive care unit in Egypt.

Authors:  Doaa Mohammad Ghaith; Reem Mostafa Hassan; Ahmed Mohamed Hasanin
Journal:  Ann Saudi Med       Date:  2015 Nov-Dec       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.